As health reform brings a focus on the budget for Medicare, a little-known but influential group with links to the AMA and specialty societies is getting a closer look. It's called the Relative Value Scale Update Committee and it is at the center of a debate over whether doctors have too much control over the flow of taxpayer dollars in the Medicare program. Dr. Barbara Levy, chair of the RUC tells Bruce Japsen about how this group works and the importance of what it does. In a previous segment, he spoke with Tom Scully, senior counsel in Alston & Bird, LLP, in Washington, DC, and former head of the Centers for Medicare & Medicaid Services, about the other side of this debate.
An AMA Perspective on the Relative Value Scale Update Committee

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
As health reform brings a focus on the budget for Medicare, a little-known but influential group with links to the AMA and specialty societies is getting a closer look. It's called the Relative Value Scale Update Committee and it is at the center of a debate over whether doctors have too much control over the flow of taxpayer dollars in the Medicare program. Dr. Barbara Levy, chair of the RUC tells Bruce Japsen about how this group works and the importance of what it does. In a previous segment, he spoke with Tom Scully, senior counsel in Alston & Bird, LLP, in Washington, DC, and former head of the Centers for Medicare & Medicaid Services, about the other side of this debate.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
HF Management for Patients with Comorbid Conditions
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Second-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?